439 related articles for article (PubMed ID: 27170161)
1. Investigational new drugs for brain cancer.
Staedtke V; Bai RY; Laterra J
Expert Opin Investig Drugs; 2016 Aug; 25(8):937-56. PubMed ID: 27170161
[TBL] [Abstract][Full Text] [Related]
2. Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.
Chen R; Cohen AL; Colman H
Curr Treat Options Oncol; 2016 Aug; 17(8):42. PubMed ID: 27334978
[TBL] [Abstract][Full Text] [Related]
3. Novel chemotherapeutics and other therapies for treating high-grade glioma.
Kang JH; Adamson C
Expert Opin Investig Drugs; 2015; 24(10):1361-79. PubMed ID: 26289791
[TBL] [Abstract][Full Text] [Related]
4. Emerging targeted therapies for glioma.
Miller JJ; Wen PY
Expert Opin Emerg Drugs; 2016 Dec; 21(4):441-452. PubMed ID: 27809598
[TBL] [Abstract][Full Text] [Related]
5. Mutations in chromatin machinery and pediatric high-grade glioma.
Lulla RR; Saratsis AM; Hashizume R
Sci Adv; 2016 Mar; 2(3):e1501354. PubMed ID: 27034984
[TBL] [Abstract][Full Text] [Related]
6. Investigational drugs for the treatment of cervical cancer.
Barra F; Lorusso D; Leone Roberti Maggiore U; Ditto A; Bogani G; Raspagliesi F; Ferrero S
Expert Opin Investig Drugs; 2017 Apr; 26(4):389-402. PubMed ID: 28274154
[TBL] [Abstract][Full Text] [Related]
7. Molecular targeted therapy in recurrent glioblastoma: current challenges and future directions.
Patel M; Vogelbaum MA; Barnett GH; Jalali R; Ahluwalia MS
Expert Opin Investig Drugs; 2012 Sep; 21(9):1247-66. PubMed ID: 22731981
[TBL] [Abstract][Full Text] [Related]
8. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathogenesis and therapeutic implications in pediatric high-grade gliomas.
Juratli TA; Qin N; Cahill DP; Filbin MG
Pharmacol Ther; 2018 Feb; 182():70-79. PubMed ID: 28830841
[TBL] [Abstract][Full Text] [Related]
10. Investigational drugs for head and neck cancer.
Bossi P; Alfieri S
Expert Opin Investig Drugs; 2016 Jul; 25(7):797-810. PubMed ID: 27054910
[TBL] [Abstract][Full Text] [Related]
11. Investigational drugs in phase II clinical trials for the treatment of neuroblastoma.
Amoroso L; Haupt R; Garaventa A; Ponzoni M
Expert Opin Investig Drugs; 2017 Nov; 26(11):1281-1293. PubMed ID: 28906153
[TBL] [Abstract][Full Text] [Related]
12. Therapy for recurrent malignant glioma in adults.
Mrugala MM; Kesari S; Ramakrishna N; Wen PY
Expert Rev Anticancer Ther; 2004 Oct; 4(5):759-82. PubMed ID: 15485312
[TBL] [Abstract][Full Text] [Related]
13. Emerging targeted treatments for malignant glioma.
Mulholland PJ; Thirlwell C; Brock CS; Newlands ES
Expert Opin Emerg Drugs; 2005 Nov; 10(4):845-54. PubMed ID: 16262566
[TBL] [Abstract][Full Text] [Related]
14. Evolving strategies: future treatment of glioblastoma.
Chamberlain M
Expert Rev Neurother; 2011 Apr; 11(4):519-32. PubMed ID: 21469925
[TBL] [Abstract][Full Text] [Related]
15. Changing paradigms for targeted therapies against diffuse infiltrative gliomas: tackling a moving target.
Carpenter CD; Alnahhas I; Gonzalez J; Giglio P; Puduvalli VK
Expert Rev Neurother; 2019 Jul; 19(7):663-677. PubMed ID: 31106606
[No Abstract] [Full Text] [Related]
16. Pediatric high-grade glioma: molecular genetic clues for innovative therapeutic approaches.
Rood BR; MacDonald TJ
J Neurooncol; 2005 Dec; 75(3):267-72. PubMed ID: 16195804
[TBL] [Abstract][Full Text] [Related]
17. Promising investigational drug candidates in phase I and phase II clinical trials for mesothelioma.
Guazzelli A; Bakker E; Tian K; Demonacos C; Krstic-Demonacos M; Mutti L
Expert Opin Investig Drugs; 2017 Aug; 26(8):933-944. PubMed ID: 28679291
[TBL] [Abstract][Full Text] [Related]
18. Preclinical therapeutic targets in diffuse midline glioma.
Meel MH; Kaspers GJL; Hulleman E
Drug Resist Updat; 2019 May; 44():15-25. PubMed ID: 31202081
[TBL] [Abstract][Full Text] [Related]
19. Small molecule inhibitors in children with malignant gliomas.
Herrington B; Kieran MW
Pediatr Blood Cancer; 2009 Sep; 53(3):312-7. PubMed ID: 19434732
[TBL] [Abstract][Full Text] [Related]
20. Novel approaches to glioma drug design and drug screening.
Patil SA; Hosni-Ahmed A; Jones TS; Patil R; Pfeffer LM; Miller DD
Expert Opin Drug Discov; 2013 Sep; 8(9):1135-51. PubMed ID: 23738794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
